---
title: "Pixantrone - Non-Hodgkin'S Lymphoma"
sidebar: mydoc_sidebar
permalink: db06193-mesh-d008228-1.html
toc: false 
---


Path ID: `DB06193_MESH_D008228_1`
{% include image.html url="images/db06193-mesh-d008228-1.png" file="db06193-mesh-d008228-1.png" alt="db06193-mesh-d008228-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C086548 | Pixantrone | Drug |
| UniProt:P11388 | DNA topoisomerase 2-alpha | Protein |
| MESH:D018736 | DNA adducts | ChemicalSubstance |
| GO:0006974 | cellular response to DNA damage stimulus | BiologicalProcess |
| GO:0030263 | apoptotic chromosome condensation | BiologicalProcess |
| GO:0008219 | cell death | BiologicalProcess |
| CL:0001063 | tumor cells | Cell |
| MESH:D008228 | Non-Hodgkin's lymphoma | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Pixantrone | INCREASES ABUNDANCE OF | Dna Adducts |
| Dna Adducts | DECREASES ACTIVITY OF | Dna Topoisomerase 2-Alpha |
| Dna Topoisomerase 2-Alpha | POSITIVELY REGULATES | Cellular Response To Dna Damage Stimulus |
| Cellular Response To Dna Damage Stimulus | POSITIVELY REGULATES | Apoptotic Chromosome Condensation |
| Apoptotic Chromosome Condensation | POSITIVELY CORRELATED WITH | Cell Death |
| Cell Death | DECREASES ABUNDANCE OF | Tumor Cells |
| Tumor Cells | MANIFESTATION OF | Non-Hodgkin'S Lymphoma |
|---------|-----------|---------|

Comment: pixantrone has not yet received FDA approval in the United States, it has been granted conditional marketing approval by the European Union.

Reference: 
  - [https://go.drugbank.com/drugs/DB06193](https://go.drugbank.com/drugs/DB06193)
  - [https://en.wikipedia.org/wiki/Pixantrone](https://en.wikipedia.org/wiki/Pixantrone)
